- 产品详情
- 产品参数
- 产品评论
Stemcell 73442 SU5416
Product Overview
SU5416 is a tyrosine kinase inhibitor best known as an ATP-competitive inhibitor of the kinase insert domain (KDR/VEGFR2/FLK1). In addition to inhibiting KDR (IC₅₀ = 1 μM), SU5416 also inhibits PDGFR (IC₅₀ = 20 μM), KIT (IC₅₀ = 30 nM), RET (IC₅₀ = 170 nM), FLT-3 (IC₅₀ = 160 nM), ABL (IC₅₀ = 11 μM), and ALK (IC₅₀ = 1.2 μM). SU5416 does not inhibit EGFR or FGFR tyrosine kinases (IC₅₀ > 100 μM; Fong et al.; Litz; Mologni et al.).
CANCER RESEARCH
· Prevents angiogenesis, thereby inhibiting tumor growth, catalysis and vascularization for a variety of cancers (Litz; Fong et al.).
· Inhibits RET-mediated transformation of NIH-3T3 mouse fibroblasts and Ba/F3 mouse pro-B cells (Mologni et al.).
DISEASE MODELING
· Causes pulmonary hypertension in SuHx rat model of pulmonary arterial hypertension, when combined with hypoxia (de Raaf et al.; Mizuno et al.).
IMMUNOLOGY
· Inhibits TGFβ1 activation and delays wound healing in rats (Haroon et al.)
CAS Number:204005-46-9
Alternative Names:NSC 696819, Semaxinib, Sugen 5416, VEGFR 2 Kinase Inhibitor
Chemical Formula:C₁₅H₁₄N₂O
Molecular Weight:238.3 g/mol
Purity:≥ 98%
Pathway:酪氨酸激酶
Target:ABL; ALK; FLT-3; KDR; KIT; PDGFR; RET
Related products
Description | Catalog # | Format |
Tamoxifen, 500 mg | 72662 | 500 mg |
Syringe - 3 cc, 100/bag | 28240 | 100 Bag |
Syringe - 3 cc, 30/bag | 28230 | 30 Bag |
SU11274, 5 mg | 73434 | 5 mg |
SU11274, 1 mg | 73432 | 1 mg |
SU9516, 10 mg | 73452 | 10 mg |
SU5416, 50 mg | 73444 | 50 mg |
SU5416, 10 mg | 73442 | 10 mg |
Stopcocks, 10/pk | 12231 | 10 pk |
Uante,您的科研物资战略合作伙伴！
重庆市寰宇安泰生物科技有限公司